ctPath: Demixing pathway crosstalk effect from transcriptomics data for differential pathway identification

Journal of Biomedical Informatics - Tập 73 - Trang 104-114 - 2017
Xin-Ping Xie1, Bin Gan2, Wulin Yang3,4, Hong-Qiang Wang2,3,4
1School of Mathematics and Physics, Anhui Jianzhu University, Hefei, Anhui, China
2Biological Molecular Information System Lab., Institute of Intelligent Machines, Hefei Institutes of Physical Science, CAS, Hefei, Anhui, China
3Center for Medical Physics and Technology, Hefei Institutes of Physical Science, CAS, Hefei, Anhui, China
4Cancer Hospital, CAS, Hefei, Anhui, China

Tài liệu tham khảo

Zhang, 2013, Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer, Cell Rep., 4, 542, 10.1016/j.celrep.2013.07.010 Natrajan, 2013, From integrative genomics to therapeutic targets, Cancer Res., 73, 3483, 10.1158/0008-5472.CAN-12-4717 TCGA, Comprehensive Molecular Characterization of Human Colon and Rectal Cancer, Nature 487 (2012) 330–337. Jiao, 2014, A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control, Bioinformatics, 30, 2360, 10.1093/bioinformatics/btu316 Hu, 2013, Identifying novel glioma associated pathways based on systems biology level meta-analysis, BMC Syst. Biol., 7, S9, 10.1186/1752-0509-7-S2-S9 Downward, 2006, Signatures guide drug choice, Nature, 439, 274, 10.1038/439274a D.N. Saunders, K.J. Falkenberg, K.J. Simpson, High-throughput approaches to measuring cell death, Cold Spring Harbor Protocols, 2014, pdb.top072561. Chen, 2012, Personal omics profiling reveals dynamic molecular and medical phenotypes, Cell, 148, 1293, 10.1016/j.cell.2012.02.009 Schweizer, 2013, Enhancing cancer drug discovery through novel cell signaling pathway panel strategy, Cancer Growth Metas., 6, 53 Hansen, 2013, Computation as the mechanistic bridge between precision medicine and systems therapeutics, Clin. Pharmacol. Ther., 93, 117, 10.1038/clpt.2012.199 Goeman, 2007, Analyzing gene expression data in terms of gene sets: methodological issues, Bioinformatics, 23, 980, 10.1093/bioinformatics/btm051 Ramanan, 2012, Pathway analysis of genomic data: concepts, methods, and prospects for future development, Trends Gen.: TIG, 28, 323, 10.1016/j.tig.2012.03.004 Khatri, 2012, Ten years of pathway analysis: current approaches and outstanding challenges, PLoS Comput. Biol., 8, e1002375, 10.1371/journal.pcbi.1002375 Hosack, 2003, Identifying biological themes within lists of genes with EASE, Genome Biol., 4, R70, 10.1186/gb-2003-4-10-r70 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U.S.A., 102, 15545, 10.1073/pnas.0506580102 Tian, 2005, Discovering statistically significant pathways in expression profiling studies, Proc. Natl. Acad. Sci. U.S.A., 102, 13544, 10.1073/pnas.0506577102 B. Efron, R. Tibshirani, On Testing the Significance of Sets of Genes, 2007, pp. 107–129. Wang, 2011, SLIM: a sliding linear model for estimating the proportion of true null hypotheses in datasets with dependence structures, Bioinformatics, 27, 225, 10.1093/bioinformatics/btq650 Glazko, 2009, Unite and conquer: univariate and multivariate approaches for finding differentially expressed gene sets, Bioinformatics, 25, 2348, 10.1093/bioinformatics/btp406 Nettleton, 2008, Identification of differentially expressed gene categories in microarray studies using nonparametric multivariate analysis, Bioinformatics, 24, 192, 10.1093/bioinformatics/btm583 Mitrea, 2013, Methods and approaches in the topology-based analysis of biological pathways, Front. Physiol., 4, 10.3389/fphys.2013.00278 Hummel, 2008, GlobalANCOVA: exploration and assessment of gene group effects, Bioinformatics, 24, 78, 10.1093/bioinformatics/btm531 Martini, 2013, Along signal paths: an empirical gene set approach exploiting pathway topology, Nucl. Acids Res., 41, e19, 10.1093/nar/gks866 Liu, 2013, Topologically inferring risk active pathways toward precise cancer classification by directed random walk, Bioinformatics, 10.1093/bioinformatics/btt373 Glaab, 2013, EnrichNet: network-based gene set enrichment analysis, Bioinformatics, 28, i451, 10.1093/bioinformatics/bts389 Jacob, 2012, More power via graph-structured tests for differential expression of gene networks, Ann. Appl. Stat., 6, 561, 10.1214/11-AOAS528 Tarca, 2009, A novel signaling pathway impact analysis, Bioinformatics, 25, 75, 10.1093/bioinformatics/btn577 Chasman, 2014, Pathway connectivity and signaling coordination in the yeast stress-activated signaling network, Mol. Syst. Biol., 10, 759, 10.15252/msb.20145120 Edelman, 2008, Modeling cancer progression via pathway dependencies, PLoS Comput Biol., 4, e28, 10.1371/journal.pcbi.0040028 Lee, 1999, Learning the parts of objects by non-negative matrix factorization, Nature, 401, 788, 10.1038/44565 Brunet, 2004, Metagenes and molecular pattern discovery using matrix factorization, Proc. Natl. Acad. Sci. U.S.A., 101, 4164, 10.1073/pnas.0308531101 Zheng, 2011, Tumor classification based on non-negative matrix factorization using gene expression data, IEEE Trans. Nanobiosci., 10, 86, 10.1109/TNB.2011.2144998 Kim, 2007, Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis, Bioinformatics, 23, 1495, 10.1093/bioinformatics/btm134 Zhang, 2012, Discovery of multi-dimensional modules by integrative analysis of cancer genomic data, Nucl. Acids Res., 40, 9379, 10.1093/nar/gks725 Yuvaraj, 2013, An efficient svm based tumor classification with symmetry non-negative matrix factorization using gene expression data, 761 Wang, 2015, jNMFMA: a joint non-negative matrix factorization meta-analysis of transcriptomics data, Bioinformatics, 31, 572, 10.1093/bioinformatics/btu679 Smyth, 2004, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol., 3, 10.2202/1544-6115.1027 Hong, 2006, RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis, Bioinformatics, 22, 2825, 10.1093/bioinformatics/btl476 Wang, 2006, Regulation probability method for gene selection, Patt. Recogn. Lett., 27, 116, 10.1016/j.patrec.2005.07.007 Fang, 2014, An integrative gene selection with association analysis for microarray data classification, Intell. Data Anal., 18, 739, 10.3233/IDA-140666 Wang, 2007, Extracting gene regulation information for cancer classification, Patt. Recogn., 40, 3379, 10.1016/j.patcog.2007.04.007 Sartor, 2009, LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data, Bioinformatics, 25, 211, 10.1093/bioinformatics/btn592 Han, 2015, ESEA: discovering the dysregulated pathways based on edge set enrichment analysis, Sci. Rep., 5, 13044, 10.1038/srep13044 Selamat, 2012, Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression, Genome Res., 22, 1197, 10.1101/gr.132662.111 Landi, 2008, Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival, PLoS ONE, 3, e1651, 10.1371/journal.pone.0001651 Su, 2007, Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme, BMC Genom., 8, 140, 10.1186/1471-2164-8-140 Cappello, 2014, Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells, Oncogene, 33, 2375, 10.1038/onc.2013.183 Catanzaro, 2014, Oncogenic ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4, Nat. Commun., 5, 10.1038/ncomms4729 Zohrabian, 2009, Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation, Anticancer Res., 29, 119 Chiu, 2007, Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes, BMC Cancer, 7, 109, 10.1186/1471-2407-7-109 Dyke, 2009, Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women, Cancer Epidemiol. Biomark. Prevent., 18, 1829, 10.1158/1055-9965.EPI-08-0962 Ece, 2005, Does Helicobacter pylori infection play a role in lung cancer?, Respiratory Med., 99, 1258, 10.1016/j.rmed.2005.02.038 Deng, 2013, Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis, Carcinogenesis, 34, 1189, 10.1093/carcin/bgt114 Berger, 2002, The mechanisms of action of PPARs, Ann. Rev. Med., 53, 409, 10.1146/annurev.med.53.082901.104018 Feige, 2006, From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions, Prog. Lipid Res., 45, 120, 10.1016/j.plipres.2005.12.002 Theocharis, 2002, Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade, Lung Cancer, 36, 249, 10.1016/S0169-5002(02)00013-2 Sasaki, 2002, Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer, Lung Cancer, 36, 71, 10.1016/S0169-5002(01)00449-4 Hazra, 2008, The role of PPARr in the cyclooxygenase pathway in lung cancer, PPAR Res., 2008, 7, 10.1155/2008/790568 Bren-Mattison, 2008, Antitumorigenic effects of peroxisome proliferator-activated receptor-r in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kB, Mol. Pharmacol., 73, 709, 10.1124/mol.107.042002 Wick, 2002, Peroxisome proliferator-activated receptor-r is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth, Mol. Pharmacol., 62, 1207, 10.1124/mol.62.5.1207 Kowanetz, 2006, Vascular endothelial growth factor signaling pathways: therapeutic perspective, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 12, 5018, 10.1158/1078-0432.CCR-06-1520 Cramer, 1989, Galactose consumption and metabolism in relation to the risk of ovaran cancer, Lancet, 334, 66, 10.1016/S0140-6736(89)90313-9 Hirata, 2009, Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways, Clin. Cancer Res., 15, 5678, 10.1158/1078-0432.CCR-09-0558 Carnero, 2000, Cell cycle and cancer, Clin. Trans. Oncol., 2, 12 Teschendorff, 2014, The dynamics of DNA methylation covariation patterns in carcinogenesis, PLoS Comput. Biol., 10, e1003709, 10.1371/journal.pcbi.1003709 Sacerdote de Lustig, 1980, Association of chagas disease and cancer, Medicina, 40, 43 Marret, 2012, Therapeutic management of uterine fibroid tumors: updated French guidelines, Euro. J. Obst. Gynecol. Reprod. Biol., 165, 156, 10.1016/j.ejogrb.2012.07.030 Waning, 2013, Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror, Cancer Cell, 24, 407, 10.1016/j.ccr.2013.10.001 http://www.kegg.jp/pathway/hsa05210. Scasso, 1998, Tuberculosis and cancer, Biomed. Pharmacother., 52, 346, 10.1016/S0753-3322(98)80128-5 Freedman, 2013, The association between cancer and amyotrophic lateral sclerosis, Cancer Caus. Control, 24, 55, 10.1007/s10552-012-0089-5 Haran, 2012, Cardiac mass and hypertrophic cardiomyopathy as aggressive presentation of primary cardiac lymphoma: a case report, J. Cancer Therapy, 03, 183, 10.4236/jct.2012.33026 Kotera, 2012, GENIES: gene network inference engine based on supervised analysis, Nucl. Acids Res., 10.1093/nar/gks459